Roche looks to personalized medicine for growth

LONDON (Reuters) - Roche Holding AG, the world's biggest maker of cancer drugs, said it would build on its drive into personalized medicine to hold onto its long-term growth momentum and said it would keep up spending on research and development. In a statement ahead of a presentation to investors in London on Wednesday, the Swiss drugmaker said it expected 19 late stage trials to read out over ...

Read more:

Roche looks to personalized medicine for growth

Related Posts

Comments are closed.